Long-term effectiveness of secondary prevention in patients with acute coronary syndrome

Aim. To investigate the levels and prevalence of main risk factors (RFs) in patients with acute coronary syndrome (ACS), to evaluate the long-term effectiveness of secondary prevention and its agreement with Russian and international guidelines (2005-2006).

Material and methods. A cross-sectional, retrospective analysis of medical histories was performed for 278 patients, hospitalized at the Moscow Regional Cardiology Centre (Zhukovsky) and State Research Centre for Preventive Medicine (Moscow) with myocardial infarction (MI). A subsequent questionnaire survey and examination of these patients provided the general information and the data on laboratory and instrumental test results, number of hospitalizations, work status dynamics, and current treatment.

Results. Both in-hospital and long-term prevalence of RFs was high: for body mass index (BMI) ≥ 25 kg/m2 – 34,62%, for systolic blood pressure (SBP) ≥140 mm Hg – 26,28%, for smoking – 18,22%, for clinical symptoms of depression and anxiety – 19,23% and 23,42%, respectively. Heart rate (HR), blood lipids, and fasting blood glucose levels were higher than the respective target levels.

Conclusion. The long-term RF prevalence in MI patients was high, with inadequate effectiveness of secondary preventive measures, and insufficient clinical implementation of existing international and local standards of CV prevention and therapy.

1. Отчет о состоянии здравоохранения в мире 1995г. Ликвидация разрывов. Женева: ВОЗ 1995; 139 с.

2. World Health Organization. The World Health Report 2002: Reducing risks, Promoting healthy life. Geneva: World Health Organization 2002; ISBN 9-2415-6207-2.

3. Оганов Р.Г., Масленникова Г.Я. Развитие профилактической кардиологии в России. Кардиоваск тер профил 2004; 3: 10-5.

4. Оганов Р.Г., Масленникова Г.Я. Смертность от сердечнососудистых и других хронических инфекционных заболеваний среди трудоспособного населения России. Кардиоваск тер профил 2002; 3: 4-8.

5. Bata IR, Gregor RD, Eastwood BJ, Wolf HK. Trends in the incidence of acute myocardial infarction between 1984 and 1993 – The Halifax County MONICA Project. Can J Cardiol 2000; 16(5): 589-95.

6. Giampaoli S, Palmieri L, Pilotto L, Vanuzzo D. Incidence and prevalence of ischemic heart disease in Italy: estimates from the MIAMOD method. Inal Heart J 2001; 2(5): 349-55.

7. Marques-Vidal P, Ruidavets JB, Cambou JP, Ferrieres J. Incidence, recurrens and case fatality rates for myocardial infarction in southwestern France, 1985 to 1993. J Heart 2000; 84(2): 171-5.

8. К здоровой России: политика и стратегия профилактики сердечно-сосудистых и других неинфекционных заболеваний в контексте реформ здравоохранения в России. Москва 1997; 97 с.

9. Государственный доклад о состоянии здоровья населения Российской федерации в 2000г. Здравоохранение Российской Федерации 2002; 1: 3-9.

10. Медико-демографические показатели в Российской федерации в 2004г. Статистические материалы. Официальное издание министерства здравоохранения и социального развития РФ. Москва 2004.

11. Marques-Vidal P, Ruidavets JB, Cambou JP, Ferrieres J. Incidence, recurrens and case fatality rates for myocardial infarction in southwestern France, 1985 to 1993. Heart 2000; 84(2): 171-5.

12. Maron DJ. Nonlipid primary and secondary prevention strategies for coronary heart disease. Clin Cardiol 1996; 19: 419-23.

13. European Guidelines on cardiovascular disease prevention in clinical practice. 3 Joint European Societies’ Task Force on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardio Vask Prev Rehabil 2003; 10(Suppl 1): S1-78.

14. EUROASPIRE Study Group. EUROASPIRE: a European Society of Cardiology survey of secondary prevention in coronary heart disease, principal result. Eur Heart J 1997; 18: 1569-82.

15. EUROASPIRE II Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results from EUROASPIRE II. Eur Heart J 2001; 22: 554-72.

16. Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology. J Hypertens 2007; 25: 1105-87.

17. European Guidelines on cardiovascular disease prevention in clinical practice. 3 Joint European Societies Task Force on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardio Vasc Prev Rehabil 2003; 10 (Suppl 1): 1-78.

18. Национальные рекомендации по диагностике и лечению больных с острым инфарктом с подъемом сегмента ST. Кардиоваск тер профил 2007; 6(8): Приложение 1.

19. ADA: Clinical practice recommendations 2007. Diabetes Care 2007; 30 (Suppl.1): 4-121.

20. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67 (6): 36170.

21. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. Circulation 2004; 110: 282-92.